Latest news

LifeVest

Germany registry shows Zoll LifeVest wearable defibrillator to be safe and...

Zoll Medical has announced that results from the largest German registry of patients who were prescribed the company’s LifeVest wearable defibrillator reaffirm that the...

Features

What is required for TAVI to become the new gold standard?

Since its introduction into clinical practice, transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of aortic stenosis and has entered international guideline recommendations.1,2...

TAVI durability: A rose by any other name is still a...

The data that Dvir presented at EuroPCR, as reported by Cardiovascular News, indicate that there is a significant increase in valve degeneration between five and seven years after a transcatheter aortic valve implantation (TAVI) device is implanted.

Videos

In this CTSNet video, filmed at the 2016 STS Annual Meeting (Phoenix, USA), Pieter Kappetein (Erasmus MC Thoraxcenter, Rotterdam, The Netherlands), Moritz Wyler von Ballmoos (Duke University Medical Center, Durham, USA), and Aurelio Chaux (Cedars-Sinai Medical Center, Los Angeles, USA) discuss the ethics...

Events

James Blankenship

Alexandra Lansky

Corrado Tamburino

NO COMMENTS